Showing posts with label TAS-102-combination of two active pharmaceutical ingredients: trifluridine. Show all posts
Showing posts with label TAS-102-combination of two active pharmaceutical ingredients: trifluridine. Show all posts
Monday, May 11, 2015

Taiho Oncology announces acceptance of TAS-102 NDA for review by FDA

›
Taiho Oncology, Inc., a subsidiary of Taiho Pharmaceutical Co., Ltd. (Japan), today announced the New Drug Application (NDA) for TAS-102...